Gilead Sciences
Gilead Sciences is a biopharmaceutical company that develops and commercialises therapeutics products. Gilead's Irish operations are responsible for manufacturing, quality control, packaging, and the release and distribution of the company's products in the EU and other international locations.
Financial Data
-
31st Dec 18 Source: CRO
- €2.1 billion turnover
-
€132.9 million
profit - 375 employees
-
31st Dec 17 Source: Estimated
- €2.3 billion turnover
- 250 employees
- 9 more years available »
Ranking
By Turnover
(€2.1 billion)- 53rd in Top Companies
- 10th in Health
- 8th in Pharma
By Employees
(375)- 438th in Top Companies
- 64th in Health
- 42nd in Pharma
-
- 375
- €2.1 billion
Employees
- David Cadogan Vice President}
Latest News
- 4:09pm Avant Money’s Spanish owner forecasts higher loan growth
- 3:34pm Court must rehear part of 25-year-old VRT case about valuing imported cars
- 3:14pm Aryzta investors told to convert Irish stock or risk a limited market
- 2:26pm Hungary becomes first EU state to approve Russia’s Covid vaccine
- 1:41pm Cairn Homes’ RTÉ site plans delayed after court quashes planning permission